A bipartisan bill filed last week by two Ohio House lawmakers would cap out-of-pocket costs for insulin and devices used in the treatment of diabetes. The move comes after the Biden administration in 2022 capped costs for Medicare patients, and after the big manufacturers themselves have begun taking steps to bring down prices.